Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DB-1310 |
Trade Name | |
Synonyms | DB1310|DB 1310 |
Drug Descriptions |
DB-1310 is an antibody-drug conjugate (ADC) comprising an antibody targeting ERBB3 (HER3) linked to a DNA topoisomerase I inhibitor, which potentially inhibits growth of ERBB3 (HER3)-expressing tumors (PMID: 38632563). |
DrugClasses | HER3 (ERBB3) Antibody 23 |
CAS Registry Number | NA |
NCIT ID | C200456 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DB-1310 | DB-1310 | 0 | 1 |
DB-1310 + Osimertinib | DB-1310 Osimertinib | 0 | 0 |